Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy

Tara L. Spires, Jennifer D. Orne, Karen SantaCruz, Rose Pitstick, George A. Carlson, Karen H Ashe, Bradley T. Hyman

Research output: Contribution to journalArticle

247 Citations (Scopus)

Abstract

Neurofibrillary tangles form in a specific spatial and temporal pattern in Alzheimer's disease. Although tangle formation correlates with dementia and neuronal loss, it remains unknown whether neurofibrillary pathology causes cell death. Recently, a mouse model of tauopathy was developed that reversibly expresses human tau with the dementia-associated P301L mutation. This model (rTg4510) exhibits progressive behavioral deficits that are ameliorated with transgene suppression. Using quantitative analysis of PHF1 immunostaining and neuronal counts, we estimated neuron number and accumulation of neurofibrillary pathology in five brain regions. Accumulation of PHF1-positive tau in neurons appeared between 2.5 and 7 months of age in a region-specific manner and increased with age. Neuron loss was dramatic and region-specific in these mice, reaching over 80% loss in hippocampal area CA1 and dentate gyms by 8.5 months. We observed regional dissociation of neuronal loss and accumulation of neurofibrillary pathology, because there was loss of neurons before neurofibrillary lesions appeared in the dentate gyms and, conversely, neurofibrillary pathology appeared without major cell loss in the striatum. Finally, suppressing the transgene prevented further neuronal loss without removing or preventing additional accumulation of neurofibrillary pathology. Together, these results imply that neurofiforillary tangles do not necessarily lead to neuronal death.

Original languageEnglish (US)
Pages (from-to)1598-1607
Number of pages10
JournalAmerican Journal of Pathology
Volume168
Issue number5
DOIs
StatePublished - Jan 1 2006

Fingerprint

Tauopathies
Pathology
Neurons
Transgenes
Dementia
Neurofibrillary Tangles
Cause of Death
Alzheimer Disease
Cell Death
Mutation
Brain

Cite this

Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. / Spires, Tara L.; Orne, Jennifer D.; SantaCruz, Karen; Pitstick, Rose; Carlson, George A.; Ashe, Karen H; Hyman, Bradley T.

In: American Journal of Pathology, Vol. 168, No. 5, 01.01.2006, p. 1598-1607.

Research output: Contribution to journalArticle

Spires, Tara L. ; Orne, Jennifer D. ; SantaCruz, Karen ; Pitstick, Rose ; Carlson, George A. ; Ashe, Karen H ; Hyman, Bradley T. / Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy. In: American Journal of Pathology. 2006 ; Vol. 168, No. 5. pp. 1598-1607.
@article{2f8b385bb7f84b0da63dc8817f6df119,
title = "Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy",
abstract = "Neurofibrillary tangles form in a specific spatial and temporal pattern in Alzheimer's disease. Although tangle formation correlates with dementia and neuronal loss, it remains unknown whether neurofibrillary pathology causes cell death. Recently, a mouse model of tauopathy was developed that reversibly expresses human tau with the dementia-associated P301L mutation. This model (rTg4510) exhibits progressive behavioral deficits that are ameliorated with transgene suppression. Using quantitative analysis of PHF1 immunostaining and neuronal counts, we estimated neuron number and accumulation of neurofibrillary pathology in five brain regions. Accumulation of PHF1-positive tau in neurons appeared between 2.5 and 7 months of age in a region-specific manner and increased with age. Neuron loss was dramatic and region-specific in these mice, reaching over 80{\%} loss in hippocampal area CA1 and dentate gyms by 8.5 months. We observed regional dissociation of neuronal loss and accumulation of neurofibrillary pathology, because there was loss of neurons before neurofibrillary lesions appeared in the dentate gyms and, conversely, neurofibrillary pathology appeared without major cell loss in the striatum. Finally, suppressing the transgene prevented further neuronal loss without removing or preventing additional accumulation of neurofibrillary pathology. Together, these results imply that neurofiforillary tangles do not necessarily lead to neuronal death.",
author = "Spires, {Tara L.} and Orne, {Jennifer D.} and Karen SantaCruz and Rose Pitstick and Carlson, {George A.} and Ashe, {Karen H} and Hyman, {Bradley T.}",
year = "2006",
month = "1",
day = "1",
doi = "10.2353/ajpath.2006.050840",
language = "English (US)",
volume = "168",
pages = "1598--1607",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Region-specific dissociation of neuronal loss and neurofibrillary pathology in a mouse model of tauopathy

AU - Spires, Tara L.

AU - Orne, Jennifer D.

AU - SantaCruz, Karen

AU - Pitstick, Rose

AU - Carlson, George A.

AU - Ashe, Karen H

AU - Hyman, Bradley T.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Neurofibrillary tangles form in a specific spatial and temporal pattern in Alzheimer's disease. Although tangle formation correlates with dementia and neuronal loss, it remains unknown whether neurofibrillary pathology causes cell death. Recently, a mouse model of tauopathy was developed that reversibly expresses human tau with the dementia-associated P301L mutation. This model (rTg4510) exhibits progressive behavioral deficits that are ameliorated with transgene suppression. Using quantitative analysis of PHF1 immunostaining and neuronal counts, we estimated neuron number and accumulation of neurofibrillary pathology in five brain regions. Accumulation of PHF1-positive tau in neurons appeared between 2.5 and 7 months of age in a region-specific manner and increased with age. Neuron loss was dramatic and region-specific in these mice, reaching over 80% loss in hippocampal area CA1 and dentate gyms by 8.5 months. We observed regional dissociation of neuronal loss and accumulation of neurofibrillary pathology, because there was loss of neurons before neurofibrillary lesions appeared in the dentate gyms and, conversely, neurofibrillary pathology appeared without major cell loss in the striatum. Finally, suppressing the transgene prevented further neuronal loss without removing or preventing additional accumulation of neurofibrillary pathology. Together, these results imply that neurofiforillary tangles do not necessarily lead to neuronal death.

AB - Neurofibrillary tangles form in a specific spatial and temporal pattern in Alzheimer's disease. Although tangle formation correlates with dementia and neuronal loss, it remains unknown whether neurofibrillary pathology causes cell death. Recently, a mouse model of tauopathy was developed that reversibly expresses human tau with the dementia-associated P301L mutation. This model (rTg4510) exhibits progressive behavioral deficits that are ameliorated with transgene suppression. Using quantitative analysis of PHF1 immunostaining and neuronal counts, we estimated neuron number and accumulation of neurofibrillary pathology in five brain regions. Accumulation of PHF1-positive tau in neurons appeared between 2.5 and 7 months of age in a region-specific manner and increased with age. Neuron loss was dramatic and region-specific in these mice, reaching over 80% loss in hippocampal area CA1 and dentate gyms by 8.5 months. We observed regional dissociation of neuronal loss and accumulation of neurofibrillary pathology, because there was loss of neurons before neurofibrillary lesions appeared in the dentate gyms and, conversely, neurofibrillary pathology appeared without major cell loss in the striatum. Finally, suppressing the transgene prevented further neuronal loss without removing or preventing additional accumulation of neurofibrillary pathology. Together, these results imply that neurofiforillary tangles do not necessarily lead to neuronal death.

UR - http://www.scopus.com/inward/record.url?scp=33646519920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646519920&partnerID=8YFLogxK

U2 - 10.2353/ajpath.2006.050840

DO - 10.2353/ajpath.2006.050840

M3 - Article

C2 - 16651626

AN - SCOPUS:33646519920

VL - 168

SP - 1598

EP - 1607

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -